Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

9.520 +1.100 (+13.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Why Fortrea (FTRE) Shares Are Sliding Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 6.3% in the afternoon session after negative news weighed on the broader healthcare sector, including a new U.S. government... 
Via StockStory
Topics Artificial Intelligence Initial Public Offering World Trade
Fortrea Appoints William Sharbaugh to Board of Directors
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Fortrea Holdings Inc
Via GlobeNewswire
Earnings Scheduled For August 6, 2025
 
Via Benzinga
3 Small-Cap Stocks We Find Risky
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Why Fortrea (FTRE) Stock Is Trading Up Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 4.5% in the afternoon session after Baird raised its price target on the stock to $14.00. This positive analyst action adds to... 
Via StockStory
Topics Artificial Intelligence Economy Initial Public Offering
Demystifying Fortrea Holdings: Insights From 6 Analyst Reviews
 
Via Benzinga
3 Stocks Under $10 We Find Risky
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as... 
Via StockStory
Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
Topics Economy
Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
Reflecting On Drug Development Inputs & Services Stocks’ Q2 Earnings: Fortrea (NASDAQ:FTRE)
Looking back on drug development inputs & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Fortrea (NASDAQ:FTRE) and its peers. 
Via StockStory
LGI Homes, Moderna, Fortrea, 10x Genomics, and Cogent Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S.... 
Via StockStory
Topics Economy Stocks
3 Cash-Burning Stocks We’re Skeptical Of
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
Via StockStory
Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Artificial Intelligence Economy
1 Healthcare Stock to Own for Decades and 2 That Underwhelm
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six... 
Via StockStory
Topics Stocks
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know
A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index... 
Via StockStory
Topics Bonds Economy Stocks
FTRE Q2 Deep Dive: Revenue Growth Driven by Clinical Pharmacology and Operational Restructuring
Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.2% year on year to $710.3 million. The company’s full-year... 
Via StockStory
1 Russell 2000 Stock with Solid Fundamentals and 2 We Find Risky
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
Fortrea (FTRE) Q2 Revenue Jumps 7%
Via The Motley Fool
Topics Artificial Intelligence
Why Fortrea (FTRE) Shares Are Sliding Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 4.4% in the afternoon session after the company reported mixed second-quarter financial results, where a massive net loss... 
Via StockStory
Fortrea (NASDAQ:FTRE) Reports Bullish Q2, Stock Soars
Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.2% year on year to $710.3 million. The company’s... 
Via StockStory
FORTREA HOLDINGS INC (NASDAQ:FTRE) Surges 14.6% After Q2 2025 Earnings Crush Estimates
FORTREA HOLDINGS INC (FTRE) reported strong Q2 2025 earnings, beating revenue and EPS estimates, sparking a 14.6% pre-market surge. Revenue hit $710.3M, exceeding forecasts by 10.6%, while EPS... 
Via Chartmill
Fortrea Reports Second Quarter 2025 Results
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea (FTRE) Reports Earnings Tomorrow: What To Expect
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting results this Wednesday before market open. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Fortrea Holdings Inc
Via GlobeNewswire
Wayfair, CommScope Holding, Steelcase, IDEXX Laboratories And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
What 6 Analyst Ratings Have To Say About Fortrea Holdings
 
Via Benzinga
Levi &amp; Korsinsky Notifies Shareholders of Fortrea Holdings Inc. (FTRE) of a Class Action Lawsuit and an Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.